174 related articles for article (PubMed ID: 21993388)
1. Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?
Rezaieyazdi Z; Sahebari M; Hatef MR; Abbasi B; Rafatpanah H; Afshari JT; Esmaily H
Lupus; 2011 Dec; 20(14):1494-500. PubMed ID: 21993388
[TBL] [Abstract][Full Text] [Related]
2. Elevation of serum CXCL13 in SLE as well as in sepsis.
Schiffer L; Kielstein JT; Haubitz M; Lührs H; Witte T; Haller H; Kümpers P; Schiffer M
Lupus; 2011 Apr; 20(5):507-11. PubMed ID: 21078761
[TBL] [Abstract][Full Text] [Related]
3. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.
Soyfoo MS; Roth J; Vogl T; Pochet R; Decaux G
J Rheumatol; 2009 Oct; 36(10):2190-4. PubMed ID: 19755614
[TBL] [Abstract][Full Text] [Related]
4. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
[TBL] [Abstract][Full Text] [Related]
5. Studies of serum C-reactive protein in systemic lupus erythematosus.
Williams RC; Harmon ME; Burlingame R; Du Clos TW
J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436
[TBL] [Abstract][Full Text] [Related]
6. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
7. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis.
Abdel-Wahab AF; Fathy O; Al-Harizy R
Arab J Nephrol Transplant; 2013 Jan; 6(1):11-20. PubMed ID: 23282228
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
[TBL] [Abstract][Full Text] [Related]
9. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
10. Correlation between serum levels of soluble Fas (CD95/Apo-1) with disease activity in systemic lupus erythematosus patients in Khorasan, Iran.
Sahebari M; Hatef MR; Rezaieyazdi Z; Abbasi M; Abbasi B; Mahmoudi M
Arch Iran Med; 2010 Mar; 13(2):135-42. PubMed ID: 20187668
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
[TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
16. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients?
Umare V; Nadkarni A; Nadkar M; Rajadhyksha A; Khadilkar P; Ghosh K; Pradhan VD
J Postgrad Med; 2017; 63(2):92-95. PubMed ID: 27531690
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
O'Neill SG; Giles I; Lambrianides A; Manson J; D'Cruz D; Schrieber L; March LM; Latchman DS; Isenberg DA; Rahman A
Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
[TBL] [Abstract][Full Text] [Related]
18. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
Wais T; Fierz W; Stoll T; Villiger PM
J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH
Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
Lozovoy MA; Simão AN; Hohmann MS; Simão TN; Barbosa DS; Morimoto HK; Reiche EM; Cecchini R; Dichi I
Lupus; 2011 Nov; 20(13):1356-64. PubMed ID: 21868433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]